In pathological conditions similar to tumor progression, such as skin fibrosis, FAK is a major effector molecule that is activated downstream of the STAT3 pathway, and it has been shown to correlate with activation of the ERK-CCL2 signaling pathway. Here, PTK2 is linked to neoplasm.